CEL-SCI Corp. (CVM)
6.65
-0.01
(-0.15%)
USD |
NYAM |
Dec 10, 14:14
CEL-SCI Cash from Financing (Quarterly): 3.808M for June 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | 6.654M |
| IGC Pharma, Inc. | 3.11M |
| NovaBay Pharmaceuticals, Inc. | -1.319M |
| Protalix Biotherapeutics, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.3282M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.940M |
| Free Cash Flow | -17.36M |
| Free Cash Flow Per Share (Quarterly) | -0.9492 |
| Free Cash Flow to Equity (Quarterly) | -3.372M |
| Free Cash Flow to Firm (Quarterly) | -3.768M |
| Free Cash Flow Yield | -4.79% |